This trial is observing how well different newborns' lungs function. It is measuring how well they respond to treatments given to newborns with lung diseases.
1 Primary · 13 Secondary · Reporting Duration: 40 weeks' postmenstrual age or discharge until 2 years
Experimental Treatment
1098 Total Participants · 1 Treatment Group
Primary Treatment: Non-invasive forced airway oscillometry · No Placebo Group · N/A
Age 1 - 2 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: